Crossmark

Design, implementation and usability analysis of patient empowerment in ADLIFE project via patient reported outcome measures and shared decision making

Crossref DOI link: https://doi.org/10.1186/s12911-024-02588-y

Published Online: 2024-06-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Erturkmen, Gokce B. Laleci

Juul, Natassia Kamilla

Redondo, Irati Erreguerena

Gil, Ana Ortega

Berastegui, Dolores Verdoy

de Manuel, Esteban

Yuksel, Mustafa

Sarigul, Bunyamin

Yilmaz, Gokhan

Choi Keung, Sarah N. L. I. M.

Arvanitis, Theodoros N.

Syse, Thea Damkjaer

Bloemeke-Cammin, Janika

Kaye, Rachelle

Sorknæs, Anne Dichmann

,
Funding

Funding for this research was provided by:

European Commission (875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209, 875209)
License Information

Text and Data Mining valid from 2024-06-28

Version of Record valid from 2024-06-28
More Information

Article History

Received: 29 June 2023

Accepted: 25 June 2024

First Online: 28 June 2024

Declarations

:

: The study is conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committees of Basque Country (protocol code PI2021016 and date of approval 12/05/2022).” for studies involving humans.The usability study for PEP has received ethical approval from the University of Warwick Biomedical and Scientific Research Ethics Committee (BSREC 96/21–22) on 12 April. Informed consent has been obtained from all participants involved in the usability study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below